Combined use of Feitai capsule and antituberculosis agents in initial treatment of pulmonary tuberculosis

Objective To evaluate the clinical efficacy and safety of Feitai capsule and antituberculosis agents in initially treatment of pulmonary tuberculosis patients. Methods:38 patients were administrated with Feitai capsule and antituberculosis agents for6 months. 15 patients were treated with placebo and anti-tuberculosis angents for 6 months. The changes were observed at 2 and 6 months after treatment, which were changes of sputum smear from positive to negative, lesions and cavities on radiography. Adverse drug reactions were observed during the whole treatment course. Results:The duration of change in sputum tuberculosis smear from positive to negative was short and the absorption rates of lesions and cavities on radiography were greater in the group of Feitai capsule than those of the control group. No evident adverse drug reaction was found. Conclusion: Feitai capsule is a kind of traditional Chinese medicine that accelerates the improvement of pulmonary tuberculosis patients at initial treatment stage as antituberculosis agent. It is effective and safe.